International team collaborates in fight against drug-resistant malaria

A team of scientists from Stanford University, the Universities of Melbourne, the Medical Research Council in Cambridge, and the University of California, San Francisco have made a significant breakthrough in finding first-defense treatments for the growing resistance of malaria parasites. Read More »

Study evaluates four-drug TB treatment for HIV/AIDS patients

Johns Hopkins University School of Medicine, the University of North Carolina, and the University of Pennsylvania researchers recently published a report stating there is not any additional benefit for advanced HIV/AIDS patients to receive four tuberculosis drugs in lieu of isonazid alone. Read More »

New vaginal lactobacillus for neutralizing HIV-1 antibody fragments

Scientists from Osel Inc. and their partners have engineered a vaginal lactobacillus that is designed to generate neutralizing antibody fragments against HIV-1 infections. Read More »

NIH commemorates World Tuberculosis Day

The National Institute of Allergy and Infectious Diseases, a branch of the National Institutes of Health, recently released a statement verifying the organization’s commitment to researching, preventing and treating tuberculosis. Read More »

Scientists advance parameter selection, verification techniques in HIV model

In a paper recently published in SIAM Journal on Uncertainty Quantification, Mami Wentworth, Ralph Smith and H.T. Banks used robust parameter selection and verification techniques on a dynamic HIV model. Read More »

Purdue team creates 3-D map of Zika virus

Purdue University researchers recently created a near-atomic level map of the Zika virus, which could spark vaccines, antiviral drugs, antibodies and a diagnostic test capable of differentiating Zika virus infections from dengue infections. Read More »

Wistar Institute research suggests strategies for combating Chikungunya virus

A Wistar Institute study recommends combating Chikungunya virus (CHIKV) through boosting the immune system by rapidly producing CHIKV antibodies as well as a traditional DNA-based vaccine. Read More »

Influenza vaccine could reduce risk of stillbirths

Mothers who receive seasonal influenza vaccinations may have a reduced chance of stillbirth according to a new study of midwife records for just over 58,000 births in Western Australia. Read More »

NIH organizations issue report on Ebola patient's care

A new report from various organizations under the National Institutes of Health details the clinical course of a 34-year-old American with Ebola virus disease who received intensive supportive care through a clinical trial at the NIH Special Clinical Studies Unit. Read More »

UNICEF asissts Zambia in cholera outbreak response

UNICEF recently provided the Zambian Ministry of Health with supplies worth $12,000 to aid in the response to an outbreak of cholera, which has so far seen 549 cases and four deaths. Read More »

Study suggests modified cholesterol can inhibit growth of drug-resistant tuberculosis

Researchers from the University of Queensland and University of California San Francisco have found that modified cholesterol can inhibit the growth of the bacterium that causes tuberculosis, a disease that claims a life every 21 seconds. Read More »

German researchers find no benefit to use of rilpivirine on HIV children and adolescents.

BodyThe German Institute for Quality and Efficiency in Health Care (IQWiG) recently found that there is no proven added benefit for HIV-1 infected children and adolescents treated with rilpivirine as opposed to the appropriate comparator therapy. Read More »

African Union discusses governmental response to Ebola outbreak

The African Union Department of Social Affairs recently held a high-level round table on governance issues in the various responses to the Ebola virus, focusing on the lessons learned and the best practices for resilient health systems moving forward. Read More »

NIAID begins enrollment in clinical trials of HIV-preventing antibody

Researchers recently began enrollment for the first of two multinational clinical trials, known as the AMP Studies, which are sponsored by the National Institute of Allergy and Infectious Diseases and could provide a safe, tolerable and effective way to prevent HIV infection. Read More »

Immunovaccine, Leidos to collaborate on Zika virus vaccine

Clinical stage vaccine producer Immunovaccine Inc. and Leidos, which focuses on national security and infrastructure solutions, will partner to develop a vaccine against Zika virus and infection. Read More »

Study finds resistance to CRISPR/Cas9 platform when used to target HIV

A recently published study found that the CRISPR/Cas9 gene-editing platform can inhibit viral replication through single mutations, but that viruses that escape the targeted approach become more difficult to target. Read More »

Mymetics Corp. HIV vaccine candidate shows potential

A recent study of a Mymetics Corp. HIV vaccine candidate showed that it generated significant protection against repeated AIDS virus exposures in groups of 12 female monkeys. Read More »

Researchers study progression of HIV during early stages of infection

Research from several collaborating laboratories, initiated through the Consortium for AIDS Vaccine Research, examined monkeys exposed to Simian Immunovirus infection to determine what happens during the earliest stages of HIV infection in humans. Read More »

Oxford researchers find new TB biomarkers

Researchers led by Oxford University scientists have identified new biomarkers for tuberculosis that will further our understanding of the variable effectiveness of the Bacillus Calmette-Guérin (BCG) vaccine and aid in the development of new vaccines. Read More »

Missouri studies examine collaboration between HIV-focused agencies

Two recently published studies by the University of Missouri’s Nidhi Khosla examine cooperation between agencies and organizations serving people with HIV in Baltimore and offer suggestions for improving their services and measuring their collaboration. Read More »